467 related articles for article (PubMed ID: 16816866)
1. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
[TBL] [Abstract][Full Text] [Related]
2. [Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia].
Mata Rebón M; Bartolomé Husson C; Bernárdez Hermida I
Enferm Infecc Microbiol Clin; 1998 Jan; 16(1):25-7. PubMed ID: 9542305
[TBL] [Abstract][Full Text] [Related]
3. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of human parvovirus B19 in Taiwan.
Lin KH; You SL; Chen CJ; Wang CF; Yang CS; Yamazaki S
J Med Virol; 1999 Feb; 57(2):169-73. PubMed ID: 9892403
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus B19 and C-reactive protein in blood bank donors: implications for hygiene hypothesis research.
O'Bryan TA; Wright WF
Lupus; 2010 Nov; 19(13):1557-60. PubMed ID: 20679283
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients.
Mauser-Bunschoten EP; Zaaijer HL; van Drimmelen AA; de Vries S; Roosendaal G; van den Berg HM; Lelie PN
Vox Sang; 1998; 74(4):225-7. PubMed ID: 9691402
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
Türk Dağı H; Ozdemir M; Baykan M; Baysal B
Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.
Gonzalez B; Larrañaga C; León O; Díaz P; Miranda M; Barría M; Gaggero A
J Rheumatol; 2007 Jun; 34(6):1336-40. PubMed ID: 17477467
[TBL] [Abstract][Full Text] [Related]
10. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
11. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
Pfrepper KI; Enders M; Motz M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):362-5. PubMed ID: 16316402
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
13. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.
Ke L; He M; Li C; Liu Y; Gao L; Yao F; Li J; Bi X; Lv Y; Wang J; Hirsch ML; Li W
Transfusion; 2011 Sep; 51(9):1909-18. PubMed ID: 21382040
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
González M; Hassanhi M; Rivera S; Bracho MP
Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
[TBL] [Abstract][Full Text] [Related]
16. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
Kozireva SV; Zestkova JV; Mikazane HJ; Kadisa AL; Kakurina NA; Lejnieks AA; Danilane IN; Murovska MF
J Rheumatol; 2008 Jul; 35(7):1265-70. PubMed ID: 18484700
[TBL] [Abstract][Full Text] [Related]
17. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
Tzang BS; Tsay GJ; Lee YJ; Li C; Sun YS; Hsu TC
Clin Chim Acta; 2007 Mar; 378(1-2):59-65. PubMed ID: 17169353
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
Chehadeh W; Halim MA; Al-Nakib W
Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
[TBL] [Abstract][Full Text] [Related]
20. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]